XML 26 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets GOODWILL AND INTANGIBLE ASSETS
Goodwill
Goodwill is tested annually for impairment at the reporting unit level during the fourth quarter or upon the identification of triggering events that would more likely than not reduce the fair value of goodwill below its carrying amount. There were no indicators of impairment as of September 30, 2025. The balance of the Company’s goodwill was $40.3 million as of September 30, 2025 and December 31, 2024.
Intangible Assets
The following table presents details of the Company’s intangible assets as of September 30, 2025 (dollars in thousands):
September 30, 2025
Gross Carrying AmountAccumulated AmortizationForeign Currency TranslationNet Carrying AmountWeighted Average Remaining Useful Life
(In Years)
Intangible assets with finite lives:
Acquired and developed technology$36,517 $(23,396)$(2,198)$10,923 5.9
Customer relationships25,581 (11,967)(1,728)11,886 7.3
Commercialization rights11,579 (6,707)— 4,872 3.8
Trademarks and tradenames4,860 (2,341)(247)2,272 6.8
Total intangible assets with finite lives78,537 (44,411)(4,173)29,953 
Intangible assets with indefinite lives:
Acquired in-process technology1,250 — — 1,250 
Favorable license agreement
2,243 — — 2,243 
Total intangible assets with indefinite lives
3,493 — — 3,493 
Total intangible assets$82,030 $(44,411)$(4,173)$33,446 
The following table presents details of the Company’s intangible assets as of December 31, 2024 (dollars in thousands):
December 31, 2024
Gross Carrying AmountAccumulated AmortizationForeign Currency TranslationNet Carrying AmountWeighted Average Remaining Useful Life
(In Years)
Intangible assets with finite lives:
Acquired and developed technology$37,367 $(21,357)$(2,531)$13,479 6.6
Customer relationships25,718 (10,777)(2,332)12,609 8.4
Commercialization rights11,579 (5,760)— 5,819 4.6
Trademarks and tradenames5,220 (2,094)(356)2,770 8.5
Total intangible assets with finite lives79,884 (39,988)(5,219)34,677 
Intangible assets with indefinite lives:
Acquired in-process technology1,250 — — 1,250 
Favorable license agreement
2,257 — — 2,257 
Total intangible assets with indefinite lives
3,507 — — 3,507 
Total intangible assets$83,391 $(39,988)$(5,219)$38,184 
As of September 30, 2025, other than the $1.7 million intangible asset that was impaired and written off during the three months ended September 30, 2025, the Company did not identify any impairment indicators suggesting that the carrying value of the intangible assets was not recoverable.
The following table summarizes the Company’s amortization expense of finite-lived intangible assets (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of testing services$348 $329 $1,041 $987 
Cost of product447 419 1,301 1,250 
Cost of patient and digital solutions152 170 457 679 
Sales and marketing
655 634 1,931 1,895 
Total$1,602 $1,552 $4,730 $4,811 
The following table summarizes the Company’s estimated future amortization expense of intangible assets with finite lives as of September 30, 2025 (in thousands):
Years Ending December 31,Total
Remainder of 2025$1,585 
20265,305 
20275,292 
20285,292 
20294,577 
Thereafter7,902 
Total future amortization expense$29,953